Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ASTRAZENECA : Deutsche Bank reiterates its Buy rating

10/26/2021 | 06:48am EST

In a research note published by Emmanuel Papadakis, Deutsche Bank advises its customers to buy the stock. The target price remains unchanged at GBX 10500.


ę MarketScreener with dpa-AFX Analyser 2021
All news about ASTRAZENECA PLC
06:10aMarketScreener's World Press Review - December 9, 2021
05:44aEvusheld (formerly AZD7442) long-acting antibody combination authorised for emergency u..
AQ
04:21aDemand still strong for India-made AstraZeneca vaccine doses - COVAX's GAVI
RE
04:12aAstraZeneca's India-Made COVID-19 Vaccine Still in Strong Demand, Gavi Says
MT
12/08AstraZeneca's Evusheld Granted Emergency Use Authorization by US FDA to Prevent COVID-1..
MT
12/08EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency u..
BU
12/08New COVID-19 antibody drug OK'd to protect most vulnerable
AQ
12/08US OKs new COVID-19 antibody drug for high-risk patients
AQ
12/08AstraZeneca Receives FDA Authorization for Antibody Therapy Evusheld to Prevent COVID-1..
MT
12/08COVID SCIENCE-Mixing vaccines boosts immune response; experimental saliva test nearly a..
RE
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 926 M - -
Net income 2021 2 724 M - -
Net Debt 2021 24 888 M - -
P/E ratio 2021 40,5x
Yield 2021 2,57%
Capitalization 170 B 170 B -
EV / Sales 2021 5,41x
EV / Sales 2022 4,42x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 109,42 $
Average target price 137,02 $
Spread / Average Target 25,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC13.11%169 817
JOHNSON & JOHNSON4.42%432 641
ROCHE HOLDING AG20.68%329 493
PFIZER, INC.39.64%288 501
NOVO NORDISK A/S73.12%256 630
ELI LILLY AND COMPANY45.17%221 499